Showing 2201-2210 of 10623 results for "".
The Role of HCC Coding in Dermatology
https://reachmd.com/topics/practice-management/the-role-of-hcc-coding-in-dermatology/56303/Hierarchical Condition Category (HCC) coding has become a cornerstone for risk adjustment in modern healthcare systems, serving to ensure appropriate reimbursement for providers managing patients with complex medical needs.Improving Home BP Monitoring: Inside the AMA’s Validated Device Listing
https://reachmd.com/programs/perspectives-ama/ama-validated-devices-for-home-bp-monitoring/33011/Accurate home blood pressure monitoring is vital for effective hypertension care, and the AMA’s Validated Device Listing (VDL) helps clinicians and patients confidently select devices that meet rigorous international accuracy standards. Learn more about how the VDL ensures device reliability and thePerioperative Immunotherapy Strategies in Resectable NSCLC Care
https://reachmd.com/programs/project-oncology/perioperative-immunotherapy-resectable-nsclc/49111/The treatment paradigm for early-stage resectable non-small cell lung cancer (NSCLC) is rapidly evolving with the integration of perioperative immunotherapy. To learn more about the structure, rationale, and clinical impact of these regimens, Dr. Charles Turck speaks with Dr. Martin Dietrich, AssistAnti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
https://reachmd.com/programs/medical-industry-feature/anti-amyloid-therapy-early-alzheimers-real-world/48941/Explore the clinical use of the anti-amyloid therapy LEQEMBI® (lecanemab-irmb) for early Alzheimer’s disease in this four-part, on-demand video series. The program offers expert-led guidance on patient selection and monitoring, 4-year efficacy and safety data, and emerging real-world evidence. FeatuOptimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
https://reachmd.com/programs/project-oncology/optimizing-multiple-myeloma-care-advances-for-newly-diagnosed-patients/26582/Tune in to learn about the latest treatments for patients with newly diagnosed multiple myeloma.Partnering for Better Hypertension Outcomes: How AMA and Azara Support Providers
https://reachmd.com/programs/perspectives-ama/precision-measurements-patient-collaborations-hypertension-management/33010/By embedding evidence-based metrics directly into existing workflows, the partnership between the American Medical Association (AMA) and Azara Healthcare supports providers in proactively managing hypertension. To learn more about how integrating the AMA MAP™ Hypertension Quality Improvement ProgramTailoring Inflammatory Bowel Disease Care: Selection Criteria and Timing
https://reachmd.com/programs/gi-insights/tailoring-inflammatory-bowel-disease-care-selection-criteria-and-timing/35591/As the advanced treatment landscape for inflammatory bowel disease continues to expand, selecting the right therapies has become more complex, with efficacy, safety, patient preferences, disease phenotypes, and more as factors to consider. Learn how to effectively navigate these therapeutic optionsHighlights from VBS 2026: From Care Innovations to Clinician Wellness
https://reachmd.com/programs/eye-on-ocular-health/vbs-2026-innovations-clinician-wellness/56547/The 2026 Vit-Buckle Society (VBS) Annual Meeting featured candid case-based discussions on real-world complications and innovative approaches, as well as sessions dedicated to promoting physician wellness. Catch up on insights from this year's meeting with Dr. Akshay Thomas, a vitreoretinal surgeonRethinking Potassium Restriction in Chronic Kidney Disease Management
https://reachmd.com/programs/clinicians-roundtable/potassium-restriction-ckd-management/54816/For decades, potassium restriction has been a cornerstone of dietary management in patients with chronic kidney disease (CKD), but is it always necessary? Here to answer that exact question is Dr. Deborah Clegg. Since many patients may already be consuming potassium at restricted levels, she emphasiUnpacking the Genetics of Friedreich’s Ataxia
https://reachmd.com/programs/neurofrontiers/genetics-friedreichs-ataxia/54669/Friedreich’s ataxia is a mitochondrial disorder driven by GAA repeat expansions in the frataxin gene, leading to impaired iron-sulfur cluster formation and cellular dysfunction. Tune in to hear Dr. Arnie Koeppen explain the genetic and epigenetic mechanisms underlying frataxin deficiency and their i